Search Results
Updates from the MAHOGANY study in gastric cancer
MAHOGANY: margetuximab in gastric cancer
MAHOGANY: margetuximab and retifanlimab in HER2+, 1L unresectable/metastatic GEA
Latest news in gastric cancer from ASCO GI
Clinical Trials Updates for Gastric Cancer Patients
GASTHER2: trastuzumab for advanced gastric cancer
The role of immunotherapy in gastrointestinal cancers: an update from ESMO
Updates in treatments for HER2-positive GEA
Margetuximab Along With Retifanlimab in High Expressing HER2+ Gastric Cancer
Antibody Drug Conjugates for Gastric Cancer
Dr. Catenacci on Study of Margetuximab Plus Pembrolizumab in Gastric:GEJ Cancer
Promising results from the gastric cancer cohort of LEAP-005
